Dermatophagoides Pteronyssinus Extract

6 trials 1 recruiting VVarious

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

1 Recruiting

3 Completed trials

3 Sponsors

2 Countries

Phase III

Phase II/III

Phase III: 2 Phase II/III: 4

Indications tested

Allergy test positive 1

Sponsors using this IMP

ROXALL Medizin GmbH 4 Inmunotek S.L. 1 LETI Pharma S.L.U. 1

All trials

6 total

A clinical trial to evaluate the efficacy and safety of a mixture of allergenic extracts of D. pteronyssinus and D. farinae, in patients suf… Pending

2025-521230-29-00 Phase III 1 country LETI Pharma S.L.U.
D. pteronyssinus and D. farinae allergen extracts. Study of the sensitivity and specificity of the prick test diagnostic preparation Pending

2025-522469-31-00 Phase III 1 country Inmunotek S.L.
Phase II-III study to assess the efficacy and safety of sublingual immunotherapy in patients suffering from house dust mite allergy. A prosp… Recruiting

2025-523119-12-00 Phase II/III 2 countries ROXALL Medizin GmbH
Phase II-III study to assess the efficacy and safety of subcutaneous cluster-immunotherapy in patients suffering from Olea europaea pollen a… Ended

2024-511383-88-00 Phase II/III 1 country ROXALL Medizin GmbH
Phase II-III study to assess the efficacy and safety of sublingual immunotherapy in patients suffering from grass pollen allergy Ended

2023-505880-35-00 Phase II/III 1 country ROXALL Medizin GmbH
Phase II-III study to assess the efficacy and safety of sublingual immunotherapy in patients suffering from birch pollen allergy Ended

2023-505567-37-00 Phase II/III 1 country ROXALL Medizin GmbH

Showing 1–6 of 6 trials

← All drugs A–Z